Article

Enhanced mass on contrast-enhanced breast MR imaging: Lesion characterization using combination of dynamic contrast-enhanced and diffusion-weighted MR images.

Department of Clinical Radiology, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.
Journal of Magnetic Resonance Imaging (Impact Factor: 2.79). 12/2008; 28(5):1157-65. DOI: 10.1002/jmri.21570
Source: PubMed

ABSTRACT To evaluate the diagnostic accuracy of a combination of dynamic contrast-enhanced MR imaging (DCE-MRI) and diffusion-weighted MR imaging (DWI) in characterization of enhanced mass on breast MR imaging and to find the strongest discriminators between carcinoma and benignancy.
We analyzed consecutive breast MR images in 270 patients; however, 13 lesions in 93 patients were excluded based on our criteria. We analyzed tumor size, shape, margin, internal mass enhancement, kinetic curve pattern, and apparent diffusion coefficient (ADC) values. We applied univariate and multivariate analyses to find the strongest indicators of malignancy and calculate a predictive probability for malignancy. We added the corresponding categories to these prediction probabilities for malignancy and calculated diagnostic accuracy when we consider category 4b, 4c, and 5 lesions as malignant and category 4a, 3, and 2 lesions as benign. In a validation study, 75 enhancing lesions in 71 patients were examined consecutively.
Irregular margin, heterogeneous internal enhancement, rim enhancement, plateau time-intensity curve (TIC) pattern, and washout TIC pattern were the strongest indicators of malignancy as well as past studies, and ADC values less than 1.1x10(-3) mm2/s were also the strongest indicators of malignancy. In a validation study, sensitivity, specificity, positive predictive value, negative predictive value, and accuracy were 92% (56/61), 86% (12/14), 97% (56/58), 71% (12/17), and 91% (68/75), respectively.
The combination of DWI and DCE-MRI could produce high diagnostic accuracy in the characterization of enhanced mass on breast MR imaging.

0 Bookmarks
 · 
197 Views
  • [Show abstract] [Hide abstract]
    ABSTRACT: To assess whether multiparametric (18)fluorodeoxyglucose positron emission tomography magnetic resonance imaging (MRI) (MP (18)FDG PET-MRI) using dynamic contrast-enhanced MRI (DCE-MRI), diffusion-weighted imaging (DWI), three-dimensional proton MR spectroscopic imaging (3D (1)H-MRSI), and (18)FDG-PET enables an improved differentiation of benign and malignant breast tumors.
    Clinical Cancer Research 06/2014; · 8.19 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: The role of magnetic resonance diffusion-weighted imaging (DWI) to differentiate between malignant and benign lesions in the breast using mean apparent diffusion coefficient (ADC) values was evaluated prospectively in this study. Fifty female patients with 61 histopathologically proven solid breast lesions underwent dynamic contrast-enhanced magnetic resonance imaging and DWI using the spin-echo echo-planar technique. ADC maps have been obtained and ADCs of the lesions were calculated without knowledge of histopathological diagnosis. Golden standard was histology to define benign and malignant lesions. Statistical analysis was used to compare ADC values in the benign and malignant group and to calculate best cut-off value for distinguishing both groups based on receiver operator-curve characteristics (ROC). Differentiation of the benign and the malignant masses revealed that the threshold value of the ADC in maximum sensitivity and specificity was 1.22×10-3 mm2/s; at this threshold sensitivity was 96.2%, its specificity was 88.5%, and its positive predictive value was 86.2%. Its negative predictive value was 96.9%, and the accuracy rate was 91.8%. ROC analysis showed an area under the curve of 0.924 (p<0.001). Breast MRI with DWI using ADC measurements can be useful in the differentiation of benign and malignant breast lesions.
    Journal of Experimental and Clinical Medicine 01/2013; 30(4):305-310.
  • [Show abstract] [Hide abstract]
    ABSTRACT: Purposes The purpose of our meta-analysis was to assess the overall diagnostic value of diffusion-weighted magnetic resonance imaging (DW-MRI) in detecting node metastases and investigate whether the apparent diffusion coefficient (ADC) value could be used to discriminate between metastatic and non-metastatic lymph nodes in patients with primary tumors. Materials and methods The meta-analysis included a total of 1,748 metastatic and 6,547 non-metastatic lymph nodes from 39 studies, including 8 different tumor types with lymph node metastases. Results The pooled sensitivity and specificity of DW-MRI were 0.82 (95 % CI 0.76–0.87) and 0.92 (95 % CI 0.88–0.94), respectively. The positive likelihood ratio (PLR), negative likelihood ratio (NLR), and the area under the curve were 9.8 (95 % CI 6.9–14.0), 0.20 (95 % CI 0.15–0.26) and 0.93 (95 % CI 0.91–0.95), respectively. The probability of 42 % can be viewed as the cutoff pretest probability for DW-MRI to diagnosis lymph node metastases; when the more chance of metastatic increased from 42 % that the pretest probability was estimated, it was more suitable to emphasize on “ruling in,” on the contrary, and when the more chance of metastatic decreased from 42 %, it was more suitable to emphasize on “ruling out.” Furthermore, the mean ADC value of metastatic lymph nodes was significantly lower than that of non-metastatic (P = 0.001). Conclusions DW-MRI is useful for differentiation between metastatic and non-metastatic lymph nodes. However, DW-MRI has a moderate diagnostic value for physician’s decision making when PLR and NLR took into consideration, while a superior ability for nodal metastases confirmation, but an inferior ability for ruling out. In the future, large-scale, high-quality trials are necessary to evaluate, respectively, their clinical value in different tumor types with nodal metastases.
    Journal of Cancer Research and Clinical Oncology 12/2014; · 3.01 Impact Factor